Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy-Reference-Cited by-同舟云学术

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

Published:2015-06-10 Issue:10 Volume:17 Page:1066-1074
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Zile Michael R.¹,Abraham William T.²,Weaver Fred A.³,Butter Christian⁴,Ducharme Anique⁵,Halbach Marcel⁶,Klug Didier⁷,Lovett Eric G.⁸,Müller‐Ehmsen Jochen⁹,Schafer Jill E.¹⁰,Senni Michele¹¹,Swarup Vijay¹²,Wachter Rolf¹³,Little William C.¹⁴

Affiliation:

1. Division of Cardiology, Department of Medicine Medical University of South Carolina 114 Doughty Street, Thurmond/Gazes, 323, Charleston, SC 29425, USA and Ralph H. Johnson Department of Veterans Affairs Medical Center Charleston SC USA

2. Division of Cardiovascular Medicine The Ohio State University Columbus OH USA

3. Division of Vascular Surgery and Endovascular Therapy, Keck School of Medicine University of Southern California Los Angeles CA USA

4. Department of Cardiology Immanuel Heart Center Bernau—Medical School Brandenburg Bernau Germany

5. Montreal Heart Institute University of Montréal Montreal Quebec Canada

6. Department of Internal Medicine III University Hospital of Cologne Cologne Germany

7. Department of Cardiology A University Hospital Lille France

8. Department of Research CVRx, Inc. Minneapolis MN USA

9. Department of Medicine Asklepios Klinik Altona Hamburg Germany

10. Department of Statistics NAMSA, Inc. Minneapolis MN USA

11. Cardiovascular Department Ospedale Papa Giovanni XXIII Bergamo Italy

12. Department of Electrophysiology Arizona Heart Hospital Phoenix AZ USA

13. Clinic for Cardiology and Pneumology University Medicine Göttingen and German Cardiovascular Research Center (DZHK) Göttingen Germany

14. Division of Cardiology University of Mississippi Medical Center Jackson MS USA

Funder

CVRx, Inc.

Minneapolis

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.299

Reference26 articles.

1. Sympathetic Nervous System Activation in Human Heart Failure

2. Depressed Heart Rate Variability as an Independent Predictor of Death in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

4. Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure

5. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating heart failure by targeting the vagus nerve;Heart Failure Reviews;2024-08-09

2. Cardiomyopathy with subclinical heart failure;Exploring the Causes, Prevention and Management of Cardiomyopathy [Working Title];2024-07-17

3. Baroreceptors as a target of device‐based neuromodulation in heart failure: Long‐term outcomes;European Journal of Heart Failure;2024-04

4. Effect of psychosocial factors on autonomic nervous system activity in patients with heart failure;Medicine;2024-03-01

5. Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction;Heart Failure Clinics;2024-01